A significant part of my academic career is dedicated to mentoring students. Below is a selection of research projects I have had the privilege of guiding at the undergraduate, postgraduate, and doctoral levels.

PhD Projects

  • Identification of potential inhibitors for acetylcholinesterase enzyme to treat Alzheimer's disease, a computational and experimental approach

    2024 | Ms. Swaroopa H M

  • Ongoing

    Novel lead identification for breast cancer treatment: A computational and experimental approach

    Ongoing | Mr. Basavana Gowda H D

  • Ongoing

    Cutting-edge approaches to Alzheimer's drug development: Computational and pharmacological perspectives

    Ongoing | Mr. B Sunil Kumar

  • Ongoing

    AI/ML-driven discovery of anticancer agents integrated with pharmacological evaluation

    Ongoing | Mr. Srinivas G

M.Pharm Projects

  • Synthesis, formulation and pharmacological evaluation of 2,5- di-hydroxybenzaldehyde for cardioprotective activity by inhibiting Rho kinase in rats

    2019 | Ms. Veena Kittur

  • Design, molecular docking, synthesis, biological evaluation, in vitro stability and protein binding studies of novel benzimidazole derivative

    2019 | Ms. Deepa R

  • Computational and experimental evaluation of some novel benzimidazole derivatives as antimicrobial agent

    2021 | Ms. Pushpa D Poojar

  • Drug repositioning for myocardial infarction: Computational and pharmacological approach

    2021 | Mr. Roy Folitartha

  • Potent lead identification for aldose reductase enzyme to treat cataract: A computational and experimental approach

    2022 | Ms. Jeevitha L

  • Hit-to-lead identification of therapeutic agents for rheumatoid arthritis: HIF-1alpha

    2022 | Ms. Shrutika Raut

  • Drug entangled carbon nanotube against breast cancer: A computational and pharmacological approach

    2022 | Mr. A Kirthi Bhushan

  • Identification of carbonic anhydrase IX selective inhibitors: A computational and experimental approach

    2023 | Ms. Sireesha Golla

  • Identification of poly ADP-ribose polymerase-1 (PARP-1) inhibitors: A computational and experimental approach

    2023 | Ms. Soundarya R

  • Anti-parkinsonian potency of test drug solid lipid nanoparticles in murine and alternative animal model

    2023 | Mr. Shannon D Almeida

  • Drug entangled multi-walled carbon nanotubes against breast cancer: A computational and pharmacological approach

    2023 | Mr. Govardhan K R

  • Exploring the therapeutic potential of test formulation against cardiovascular complications using murine and alternative animal model

    2023 | Mr. Sameera H R

  • Computational insights and experimental breakthrough in identifying next-generation acetylcholinesterase inhibitors

    2024 | Mr. Devaraj H

  • Computational insights and experimental breakthroughs in identifying cutting-edge checkpoint kinase inhibitors

    2024 | Ms. Nandini M S

  • Assessing the efficacy of ferulic acid nano formulation against breast cancer: Insights from in silico to in vivo

    2024 | Ms. Sandra Ross O S

  • Unveiling the comprehensive impact of a pirfenidone nano formulation on Alzheimer's disease: Insights from in-silico to in-vivo

    2024 | Mr. Shivarajkumar Walikar

  • Exploration of Cayratia pedata (LAM) endophytes: A comprehensive study on its anti-breast cancer potential via computational and experimental approaches

    2024 | Mr. Kumar R Karthik

  • Computational insights into FGFR1 targeted drug discovery for breast cancer therapy

    2025 | Mr. Nayan Kumar M, Ms. Tincy Biju, Mr. Chidananda V, Mr. Mohamed Safwan R, Ms. Nikita M Kittur, Ms. Sanjeevini M Hukkeri

  • Identification of novel lead compound to inhibit arginase protein for the treatment of myocardial infarction through the application of in-silico studies

    2025 | Ms. K Choudamma, Ms. Pooja L, Ms. Sindhu Priya C, Ms. Spoorthi H J, Mr. Mohd Sadhman, Ms. Lakshmi Priya P

  • Integrative approach of computational modelling and pharmacological studies to develop novel therapeutics for management of myocardial infarction

    2025 | Ms. Samiya Eram

  • Exploring endophytic fractions from Pterospermum acerifolium L. for the management of myocardial infarction: A combined computational and pharmacological evaluation

    2025 | Mr. Nayan Kumar M

  • Ongoing

    Exploration of cardioprotective effect of test drug against myocardial infarction: A computational and experimental approach

    Ongoing | Ms. Avula Jyothsna

  • Ongoing

    Unraveling the efficacy of test drug in Multiple Sclerosis treatment: A computational and experimental approach

    Ongoing | Ms. Shamooda Rahman

  • Ongoing

    Harnessing the efficacy of test drug in breast cancer treatment: A computational and experimental approach

    Ongoing | Ms. Alma Khan

  • Ongoing

    Endophyte-derived metabolites from Canarium strictum for breast cancer: A computational and experimental approach

    Ongoing | Ms. Gudivada Charishma

B.Pharm Projects

  • Discovery of anti-malarial agents from Indian medicinal plant constituents through the application of in silico molecular docking studies

    2018 | Mr. Manoj Kumar D, Ms. Navya Shree, Ms. Priyanka Eedara & Ms. Sananda Chakraborty

  • Chemo preventive effect of natural constituents against breast cancer, applications of molecular modelling studies

    2019 | Mr. Sarthak De, Ms. Aiswarya Raju, Ms. Pranamee Gogoi, Mr. Swaroop M & Ms. Swathi C

  • Discovery of anti-COVID agents from Indian plant constituents through the application of in-silico molecular docking

    2020 | Mr. Ashique Rasheed , Ms. K Ratna Kaushitha, Ms. Merin Sara Mathew, Ms. Mimi Paul & Ms. Nanda Devi

  • Repurposing of FDA approved drugs to treat melioidosis disease: A computational approach

    2021 | Ms. Jyothi M R, Mr. Pinak Vijay Paranjape, Mr.Sriram Raman Unni, Mr. Supriyo Bachhar & Mr. S Vignesh Reddy

  • In silico repurposing of FDA approved drugs for anti-cataractogenic activity

    2021 | Mr.Mohammed Azarudeen, Mr. Ajmal T K Mohammed, Mr. Rahees K Muhammed, Ms. Nikita Singh & Ms. Soumili Mallick

  • Repurposing of FDA approved drugs and natural drugs to treat migraine: A computational approach

    2022 | Mr. Jana Sankhasubhra, Mr. Gowda Koushal V, Mr. Shreyas K S, Ms. Sri Raksha L, Ms. Sushmitha N & Ms. Salimath Sushma

  • In silico repurposing of FDA approved and natural drugs for primary lateral sclerosis

    2022 | Mr. Akash Kumar Pandey, Mr. Mohammed Mutahir, Mr. Prakash Pai, Ms. Rishita Ghosh, Ms. Prakruthi S M & Mr. Gourakkanavar Shivaraj

  • Repurposing of FDA approved drug for the treatment of cystic fibrosis

    2022 | Mr. Shifan P Sonu, Ms. Deepthi N G, Ms. Keerthi R, Ms. Pruya Saumya & Ms. Seethamma Thansha

  • In silico repurposing of FDA approved and natural drugs for hereditary angioedema

    2022 | Mr. Gupta Aryan, Mr. Navas Ihsan, Mr. Kumar Karthik, Mr. Prakash Ram & Ms. Sneha Prakash

  • Spicing up pharmacology: Anti-emetic effect of cardamom unveiled in chick model

    2024 | Ms. Fathimath Rasha, Mr. Basappa V, Ms. Fida Farhath KP, Mr. Lakshmitarun T & Mr. Bava KM Hussain

  • Exploring the possible mechanism of nattokinase in cardiovascular complications: An in-silico insight

    2025 | Mr. Vishal Sanjay Kumar, Mr. Arun Ramesh Vardi, Ms. Anguluri Naga Sneha, Mr. Dhanush KV, Mr. Mohit Raj C, Mr. R Sushruth